(Q51453702)

English

In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats.

scientific article published in April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

1 reference

based on heuristic

inferred from title

author name string

Higashikawa F

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

Murakami T

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

Kaneda T

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

Takano M

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

51

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

405-410

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Interaction between grapefruit juice and midazolam in humans*

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

First-pass metabolism of midazolam by the human intestine.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Co-ordination between membrane phospholipid synthesis and accelerated biosynthesis of cytoplasmic ribonucleic acid and protein

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

The induction of hepatic cytochrome P450 3A in rats: effects of age

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

In vivo induction of cytochrome P450 CYP3A expression in rat leukocytes using various inducers

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Cultured adult rat jejunal explants as a model for studying regulation of CYP3A

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772600

21 January 2018

Identifiers

10.1211/0022357991772600

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/10385212

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51453702&oldid=1561347002"